BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14674613)

  • 21. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoliposomes for cancer therapy.
    Kontermann RE
    Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albumin: a versatile carrier for drug delivery.
    Park K
    J Control Release; 2012 Jan; 157(1):3. PubMed ID: 22119742
    [No Abstract]   [Full Text] [Related]  

  • 26. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.
    Kim KT; Lee HS; Lee JJ; Park EK; Lee BS; Lee JY; Bae JS
    Future Med Chem; 2018 Nov; 10(22):2659-2674. PubMed ID: 30499740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic uses of antioxidant liposomes.
    Stone WL; Smith M
    Mol Biotechnol; 2004 Jul; 27(3):217-30. PubMed ID: 15247495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circumventing Brain Barriers: Nanovehicles for Retroaxonal Therapeutic Delivery.
    Ovsepian SV; O'Leary VB; Ntziachristos V; Dolly JO
    Trends Mol Med; 2016 Nov; 22(11):983-993. PubMed ID: 27720365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of therapeutic molecules into the CNS.
    Emborg ME; Kordower JH
    Prog Brain Res; 2000; 128():323-32. PubMed ID: 11105691
    [No Abstract]   [Full Text] [Related]  

  • 34. CNS drug delivery: opioid peptides and the blood-brain barrier.
    Witt KA; Davis TP
    AAPS J; 2006 Feb; 8(1):E76-88. PubMed ID: 16584136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs.
    Saganuwan SA
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):32-38. PubMed ID: 28828968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomes as nanovaccine delivery systems.
    Ghaffar KA; Giddam AK; Zaman M; Skwarczynski M; Toth I
    Curr Top Med Chem; 2014; 14(9):1194-208. PubMed ID: 24678703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform.
    Saraf S; Jain A; Hurkat P; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2016; 33(5):401-432. PubMed ID: 27910741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.